Costs and quality of life of patients with multiple sclerosis in Europe

被引:265
|
作者
Kobelt, G.
Berg, J.
Lindgren, P.
Fredrikson, S.
Jonsson, B.
机构
[1] Lund Univ, Lund, Sweden
[2] Stockholm Hlth Econ, Stockholm, Sweden
[3] Huddinge Hosp, Karolinska Inst, Dept Neurol, S-14186 Huddinge, Sweden
[4] Stockholm Sch Econ, S-11383 Stockholm, Sweden
来源
关键词
D O I
10.1136/jnnp.2006.090365
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess overall resource consumption, work capacity and quality of life of patients with multiple sclerosis in nine European countries. Methods: Information on resource consumption related to multiple sclerosis, informal care by relatives, productivity losses and overall quality of life (utility) was collected with a standardised pre-tested questionnaire from 13186 patients enrolled in national multiple sclerosis societies or followed up in neurology clinics. Information on disease included disease duration, self-assessed disease severity and relapses. Mean annual costs per patient (Euro, 2005) were estimated from the societal perspective. Results: The mean age ranged from 45.1 to 53.4 years, and all levels of disease severity were represented. Between 16% and 29% of patients reported experiencing a relapse in the 3 months preceding data collection. The proportion of patients in early retirement because of multiple sclerosis ranged from 33% to 45%. The use of direct medical resources (eg, hospitalisation, consultations and drugs) varied considerably across countries, whereas the use of non-medical resources (eg, walking sticks, wheel chairs, modifications to house and car) and services (eg, home care and transportation) was comparable. Informal care use was highly correlated with disease severity, but was further influenced by healthcare systems and family structure. All types of costs increased with worsening disease. The total mean annual costs per patient (adjusted for gross domestic product purchasing power) were estimated at Euro 18000 for mild disease (Expanded Disability Status Scale (EDSS) < 4.0), Euro 36500 for moderate disease (EDSS 4.0-6.5) and Euro 62000 for severe disease (EDSS > 7.0). Utility was similar across countries at around 0.70 for a patient with an EDSS of 2.0 and around 0.45 for a patient with an EDSS of 6.5. Intangible costs were estimated at around Euro 13000 per patient.
引用
收藏
页码:918 / 926
页数:9
相关论文
共 50 条
  • [1] The costs and quality of life of multiple sclerosis in Europe
    Kobelt, G.
    Berg, J.
    Lindgren, P.
    Fredrikson, S.
    Jonsson, B.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S120 - S121
  • [2] Costs and quality of life for patients with multiple sclerosis in Belgium
    Kobelt G.
    Berg J.
    Lindgren P.
    Decoo D.
    Guillaume D.
    Neymark N.
    Sindic C.
    Vandegaer L.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S24 - S33
  • [3] Costs and quality of life in multiple sclerosis patients with spasticity
    Svensson, J.
    Borg, S.
    Nilsson, P.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (01): : 13 - 20
  • [4] Costs and quality of life in multiple sclerosis in Europe: Method of assessment and analysis
    Kobelt G.
    Berg J.
    Lindgren P.
    Jönsson B.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S5 - S13
  • [5] Costs and quality of life of multiple sclerosis in Austria
    Kobelt G.
    Berg J.
    Lindgren P.
    Baumhackl U.
    Berger T.
    Kolleger H.
    Vass K.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S14 - S23
  • [6] Costs and quality of life of multiple sclerosis in Italy
    Kobelt G.
    Berg J.
    Lindgren P.
    Battaglia M.
    Lucioni C.
    Uccelli A.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S45 - S54
  • [7] Costs and quality of life in multiple sclerosis in The Netherlands
    Kobelt G.
    Berg J.
    Lindgren P.
    Anten B.
    Ekman M.
    Jongen P.J.H.
    Polman C.
    Uitdehaag B.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S55 - S64
  • [8] Costs and quality of life of multiple sclerosis in Switzerland
    Kobelt G.
    Berg J.
    Lindgren P.
    Gerfin A.
    Lutz J.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S86 - S95
  • [9] Costs and quality of life in multiple sclerosis in The Netherlands
    Gisela Kobelt
    Jenny Berg
    Peter Lindgren
    Bert Anten
    Mattias Ekman
    Peter J. H. Jongen
    Chris Polman
    Bernard Uitdehaag
    [J]. The European Journal of Health Economics, 2007, 8 : 359 - 359
  • [10] Costs and quality of life of multiple sclerosis in Sweden
    Berg J.
    Lindgren P.
    Fredrikson S.
    Kobelt G.
    [J]. The European Journal of Health Economics, 2006, 7 (Suppl 2) : S75 - S85